Share your thoughts! Send your Letter to the Editor to rbarbieri@frontlinemedcom.com. Please include your name and the city and state in which you practice.
Expert Commentary
Should risk-reducing gynecologic surgery for BRCA mutation carriers include hysterectomy?
OBG Manag. 2016 August;28(8)
Author and Disclosure Information
Dr. Kaunitz is University of Florida Research Foundation Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida (UF) College of Medicine-Jacksonville. Dr. Kaunitz is also Medical Director and directs Menopause and Gynecologic Ultrasound Services at UF Women's Health Specialists-Emerson. He serves on the OBG Management Board of Editors.
Dr. Kaunitz reports being a consultant to Bayer and Shionogi and serving on the advisory boards of Allergan and Bayer. He has received clinical trial support, which goes to the UF College of Medicine, from Bayer and TherapeuticsMD.